If you work in pharmacovigilance or drug safety, you know how much structure goes into post-market monitoring and adverse event reporting. Clinical trials, non-interventional studies, and patient surveys are all essential, but even with these systems in place, critical signals can be missed. Even when spontaneous reports are in place, most adverse drug reactions never […]| Resolver
In May 2023, a fake image of the Pentagon on fire briefly spread across social media. Within four minutes, the Dow dropped 85 points. The image was AI-generated. The market didn’t wait for a fact-check. That moment exposed a broader risk: AI-generated misinformation moves faster than truth and puts financial markets, brand reputations and public […]| Resolver